Oxford BioDynamics Plc (LON:OBD – Get Free Report) reached a new 52-week low during trading on Friday . The company traded as low as GBX 0.17 and last traded at GBX 0.18, with a volume of 11903665 shares trading hands. The stock had previously closed at GBX 0.20.
Oxford BioDynamics Trading Down 10.0%
The company has a debt-to-equity ratio of 457.97, a current ratio of 0.88 and a quick ratio of 2.80. The company has a market capitalization of £7.72 million, a price-to-earnings ratio of -0.23 and a beta of 0.42. The business’s 50 day simple moving average is GBX 0.22 and its 200 day simple moving average is GBX 0.26.
About Oxford BioDynamics
Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.
In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.
Read More
- Five stocks we like better than Oxford BioDynamics
- Buffett Spent 60 Years Ignoring Tech and the Bill Is Coming Due
- Excited About Gold But Unsure of Its Trajectory? Try These 3 Approaches
- Dollar at a 3-Year Low: 3 Exporters Quietly Printing Money
- Water Infrastructure: Why This Boring Sector Could Get Exciting
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
